how are companies still selling compounded semaglutide Despite FDA ruling, GLP-1s giving Novo and Lilly headaches on the market Hims is in the crosshairs.

Users of these weight-loss medications typically stop taking them because they see results, Dr

The FDA took more than 30 years to update a standard for what foods could be labeled as healthy, despite calls for faster oversight of rapidly shifting labeling trends from members of Congress, doctors, and consumer advocates

Step 2: Start the process and submit your intake forms

Direct head-to-head trials have not been completed, so definitive statements must wait for more data

The UK Government MHRA warns against the misuse of falsified GLP-1RAs, often acquired without a prescription, and the growing trend of using these medications for aesthetic weight loss